Oryzon Genomics S.A. (BME:ORY)

Oryzon Genomics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Feb 21, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	192	115	133	142	210	126
Market Cap Growth	-3.09%	-13.63%	-6.58%	-32.20%	66.16%	51.89%
Enterprise Value	200	121	129	124	180	101
Last Close Price	2.96	1.89	2.48	2.70	3.50	2.78
PS Ratio	13.24	8.95	9.06	15.26	27.00	13.81
PB Ratio	-	1.55	1.96	2.27	3.39	2.32
P/TBV Ratio	-	1.56	1.97	2.29	3.39	2.34
EV/Sales Ratio	14.08	9.43	8.75	13.26	23.15	10.98
Debt / Equity Ratio	-	0.22	0.31	0.25	0.18	0.22
Asset Turnover	-	0.13	0.16	0.11	0.11	0.14
Inventory Turnover	-	30.80	8.17	3.55	1.74	2.03
Quick Ratio	-	0.87	1.34	3.75	5.47	3.55
Current Ratio	-	0.87	1.34	3.76	5.51	3.58
Return on Equity (ROE)	-	-4.34%	-5.88%	-6.37%	-4.96%	-6.94%
Return on Assets (ROA)	-	-2.71%	-3.45%	-4.63%	-3.08%	-3.25%
Return on Capital (ROIC)	-	-2.92%	-3.74%	-4.92%	-3.27%	-3.48%
Earnings Yield	-2.13%	-2.64%	-2.98%	-2.89%	-1.32%	-2.60%
FCF Yield	-0.45%	-1.35%	-2.35%	-1.93%	-2.85%
Buyback Yield / Dilution	-8.99%	-10.10%	-4.80%	-	-15.99%	-18.29%
Total Shareholder Return	-8.99%	-10.10%	-4.80%	-	-15.99%	-18.29%

Source: S&P Capital IQ. Standard template. Financial Sources.